Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 August 2018 Photo Godfrey Ndoda
UFS Mobile Clinic - an exemplary framework of innovation
Free State Department of Health and the UFS Faculty of Health Sciencesentered into a partnership set to improve primary health care in the Free State society.

The Coordinator of Community Engagement and Rural Health in the Faculty of Health Sciences, Dr René Botha, described the unveiling and handing-over ceremony of the University of the Free State (UFS) Faculty of Health Sciences’ Mobile Clinic as “an auspicious and phenomenal occasion in the history of the faculty, and the institution as a whole”.

This mobile healthcare service will align itself with the current mobile service offered by the Free State Department of Health (FSDH) and will include an optometry service. This is the first service of its kind and aims to expose students and the broader community to mobile primary healthcare on rural platforms.

This collaboration between the Faculty of Health Sciences and the FSDH is believed to change and improve lives.   

“The purpose of the clinic is to enrich current primary healthcare measures that were implemented through valuable collaborations. This will result in the betterment of community members who have limited access to healthcare resources,” explained Dr Botha.

UFS medical students have been working on a continuous healthcare programme that started in 2016. The programme operates in areas in the southern Free State, where students engage with the community, schools, clinics, and are making home visits to residents in the area. The main purpose of the programme is to find solutions to key healthcare problems in the region. 

The MEC of Health, Montseng Tsiu, addressed the audience and explained, “implementing primary healthcare holistically through the mobile clinic, will benefit residents in rural areas who have a lack of facilities”. 

According to Prof Francis Petersen, UFS Rector and Vice-Chancellor, the mobile clinic is an example of the innovation framework that cultivates the university’s mandate. The mandate stipulates the creation and maintenance of equitable partnerships with the province, the FSDH, the Department of Education, and many other crucial stakeholders that will ensure the imparting of knowledge, excellence, and quality in contributing to society.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept